Skip to content

Monte Rosa Therapeutics, Inc. GLUE Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$51.66M+96.0%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$41.74M-10.7%
Immunome logo
ImmunomeIMNM
$2.83M-32.1%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$17.55M-10.5%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$40.25M-8.5%
Biohaven logo
BiohavenBHVN
$43.4M+22.5%

Other financials

Income statement

See full
Revenue$4.2M-95.0%
Operating income-$50.0M-214%
Net income-$44.5M-195%
EPS (diluted)-$0.45-179%

Balance sheet

See full
Cash & equivalents$159.9M+104%
Total debt$39.1M-6.7%
Total equity$521.9M+89.7%
Total assets$736.4M+87.3%

Cash flow

See full
Operating cash flow-$37.4M+17.9%
CapEx$1.9M+17.7%
Free cash flow-$39.2M+16.7%

Valuation

See full
Market cap$1.75B+361%
Enterprise value$1.63B+381%
P/S40.7×+38.4×

Profitability

See full
Operating margin-345.2%
Net margin-302.6%
FCF margin-45.8%-64.9pp

Returns & leverage

See full
Return on equity-32.6%
Debt / equity0.1×-0.1×
Current ratio9.5×+3.9×

Where this comes from

Reported directly by Monte Rosa Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Monte Rosa Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Monte Rosa Therapeutics, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Monte Rosa Therapeutics, Inc.'s operating lease ROU assets?
Monte Rosa Therapeutics, Inc. (GLUE) reported operating lease ROU assets of $24.69M in Q1 2026.
How has Monte Rosa Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
Monte Rosa Therapeutics, Inc.'s operating lease ROU assets decreased by 6.0% year-over-year, from $26.26M to $24.69M.
What does operating lease ROU assets mean?
This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.